NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application March 17, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by globenewswire. Read more Source: https://www.globenewswire.com/news-release/2026/03/17/3257011/0/en/NRx-Pharmaceuticals-Nasdaq-NRXP-Announces-FDA-Bioequivalence-Determination-by-Office-of-Generic-Drugs-for-NRx-s-Preservative-Free-Ketamine-Application.html
